|
1
|
Tan YK and Fielding JW: Early diagnosis of
early gastric cancer. Eur J Gastroenterol Hepatol. 18:821–829.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ding YB, Xia TS, Wu JD, Chen GY, Wang S
and Xia JG: Surgical outcomes for gastric cancer of a single
institute in southeast China. Am J Surg. 203:217–221. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee YY and Derakhshan MH: Environmental
and lifestyle risk factors of gastric cancer. Arch Iran Med.
16:358–365. 2013.PubMed/NCBI
|
|
4
|
González CA, Sala N and Rokkas T: Gastric
cancer: Epidemiologic aspects. Helicobacter. 18 Suppl 1:S34–S38.
2013. View Article : Google Scholar
|
|
5
|
World Cancer Report 2014. World Health
Organization. Chapter 5.4. 2014
|
|
6
|
Wang M, Gu H, Qian H, Zhu W, Zhao C, Zhang
X, Tao Y, Zhang L and Xu W: miR-17-5p/20a are important markers for
gastric cancer and murine double minute 2 participates in their
functional regulation. Eur J Cancer. 49:2010–2021. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nusse R and Varmus HE: Many tumors induced
by the mouse mammary tumor virus contain a provirus integrated in
the same region of the host genome. Cell. 31:99–109. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen H, Wang Y and Xue F: Expression and
the clinical significance of Wnt10a and Wnt10b in endometrial
cancer are associated with the Wnt/β-catenin pathway. Oncol Rep.
29:507–514. 2013.PubMed/NCBI
|
|
9
|
Cadigan KM and Liu YI: Wnt signaling:
Complexity at the surface. J Cell Sci. 119:395–402. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kohn AD and Moon RT: Wnt and calcium
signaling: Beta-catenin independent pathways. Cell Calcium.
38:439–446. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mao J, Fan S, Ma W, Fan P, Wang B, Zhang
J, Wang H, Tang B, Zhang Q, Yu X, et al: Roles of Wnt/β-catenin
signaling in the gastric cancer stem cells proliferation and
salinomycin treatment. Cell Death Dis. 5:e10392014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Katoh M: WNT FGF gene clusters (Review).
Int J Oncol. 21:1269–1273. 2002.PubMed/NCBI
|
|
13
|
Mödder UI, Oursler MJ, Khosla S and Monroe
DG: Wnt10b activates the Wnt, notch, and NFκB pathways in U2OS
osteosarcoma cells. J Cell Biochem. 112:1392–1402. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoshikawa H, Matsubara K, Zhou X, Okamura
S, Kubo T, Murase Y, Shikauchi Y, Esteller M, Herman JG, Wei Wang X
and Harris CC: WNT10B functional dualism:
Beta-catenin/Tcf-dependent growth promotion or independent
suppression with deregulated expression in cancer. Mol Biol Cell.
18:4292–4303. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu H, Yin J, Wang H, Jiang G, Deng M,
Zhang G, Bu X, Cai S, Du J and He Z: FOXO3a modulates WNT/β-catenin
signaling and suppresses epithelial-to-mesenchymal transition in
prostate cancer cells. Cell Signal. 27:510–518. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiang L, Yang YD, Fu L, Xu W, Liu D, Liang
Q, Zhang X, Xu L, Guan XY, Wu B, et al: CLDN3 inhibits cancer
aggressiveness via Wnt-EMT signaling and is a potential prognostic
biomarker for hepatocellular carcinoma. Oncotarget. 5:7663–7676.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cong N, Du P, Zhang A, Shen F, Su J, Pu P,
Wang T, Zjang J, Kang C and Zhang Q: Downregulated microRNA-200a
promotes EMT and tumor growth through the wnt/β-catenin pathway by
targeting the E-cadherin repressors ZEB1/ZEB2 in gastric
adenocarcinoma. Oncol Rep. 29:1579–1587. 2013.PubMed/NCBI
|
|
19
|
Voon DC, Wang H, Koo JK, Nguyen TA, Hor
YT, Chu YS, Ito K, Fukamachi H, Chan SL, Thiery JP and Ito Y: Runx3
protects gastric epithelial cells against epithelial-mesenchymal
transition-induced cellular plasticity and tumorigenicity. Stem
Cell. 30:2088–2099. 2012. View Article : Google Scholar
|
|
20
|
Brown AM: Canonical Wnt signaling:
High-throughput RNAi widens the path. Genome Biol. 6:2312005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li C, Song G, Zhang S, Wang E and Cui Z:
Wnt3a increases the metastatic potential of non-small cell lung
cancer cells in vitro in part via its upregulation of Notch3. Oncol
Rep. 33:1207–1214. 2015.PubMed/NCBI
|
|
22
|
Qi L, Sun B, Liu Z, Cheng R, Li Y and Zhao
X: Wnt3a expression is associated with epithelial-mesenchymal
transition and promotes colon cancer progression. J Exp Clin Cancer
Res. 33:1072014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shojima K, Sato A, Hanaki H, Tsujimoto I,
Nakamura M, Hattori K, Sato Y, Dohi K, Hirata M, Yamamoto H and
Kikuchi A: Wnt5a promotes cancer cell invasion and proliferation by
receptor-mediated endocytosis-dependent and -independent
mechanisms, respectively. Sci Rep. 5:80422015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee FS, Lane TF, Kuo A, Shackleford GM and
Leder P: Insertional mutagenesis identities a member of the Wnt
gene family as a candidate oncogene in the mammary epithelium of
int-2/Fgf-3 transgenic mice. Proc Natl Acad Sci USA. 92:2268–2272.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nusse R and Varmus HE: Wnt genes. Cell.
69:1073–1087. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moon RT, Brown JD and Torres M: WNTs
modulate cell fate and behavior during vertebrate development.
Trends Genet. 13:157–162. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wend P, Runke S, Wend K, Anchondo B,
Yesayan M, Jardon M, Hardie N, Loddenkemper C, Ulasov I, Lesniak
MS, et al: WNT10B/β-catenin signalling induces HMGA2 and
proliferation in metastatic triple-negative breast cancer. EMBO Mol
Med. 5:264–279. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bui TD, Rankin J, Smith K, Huguet EL,
Ruben S, Strachan T, Harris AL and Lindsay S: A novel human gene,
WNT10B, maps to 12q13 and is expressed in human breast carcinomas.
Oncogene. 14:1249–1253. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guan X: Cancer metastases: Challenges and
opportunities. Acta Pharm Sin B. 5:402–418. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ye X and Weinberg RA:
Epithelial-mesenchymal plasticity: A central regulator of cancer
progression. Trends Cell Biol. 25:675–686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takaishi S, Okumura T and Wang TC: Gastric
cancer stem cells. J Clin Oncol. 26:2876–2882. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Arend RC, Londoño-Joshi AI, Straughn JM Jr
and Buchsbaum DJ: The Wnt/β-catenin pathway in ovarian cancer: A
review. Gynecol Oncol. 131:772–779. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Holland JD, Klaus A, Garratt AN and
Birchmeier W: Wnt signaling in stem and cancer stem cells. Curr
Opin Cell Biol. 25:254–264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bao Z, Wang Y, Yang L, Wang L, Zhu L, Ban
N, Fan S, Chen W, Sun J, Shen C and Cui G: Nucleostemin promotes
the proliferation of human glioma via Wnt/β-Catenin pathway.
Neuropathology. 36:237–249. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wangpu X, Yang X, Zhao J, Lu J, Guan S, Lu
J, Kovacevic Z, Liu W, Mi L, Jin R, et al: The metastasis
suppressor, NDRG1, inhibits ‘stemness’ of colorectal cancer via
down-regulation of nuclear β-catenin and CD44. Oncotarget.
6:33893–33911. 2015.PubMed/NCBI
|
|
37
|
Guo Q and Qin W: DKK3 blocked
translocation of β-catenin/EMT induced by hypoxia and improved
gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell. J
Cell Mol Med. 19:2832–2841. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Burkhalter RJ, Westfall SD, Liu Y and
Stack MS: Lysophosphatidic acid initiates epithelial to mesenchymal
transition and induces β-catenin-mediated transcription in
epithelial ovarian carcinoma. J Biol Chem. 290:22143–22154. 2015.
View Article : Google Scholar : PubMed/NCBI
|
